Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2007
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP Study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2007
Report date:
2007

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate
EC Number:
700-402-2
Cas Number:
860035-10-5
Molecular formula:
C11H15NO7
IUPAC Name:
1-({[(2,5-dioxopyrrolidin-1-yl)oxy]carbonyl}oxy)ethyl 2-methylpropanoate

Method

Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Metabolic activation system:
rat liver S9
Test concentrations with justification for top dose:
15, 50, 150, 500, 1500, 5000mcg/plate

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
GSk1873183A was considered to be non-mutagenic under the conditions of the test.
Executive summary:

Salmonella typhimurium strains TA1535, 1537, TA98 and TA100 and Escherichia coli strain WP2urvApKM101 were treated with solutions of GSK187318A using the Ames plate incorporation method at six dose levels in triplicate, both with and without metabolic activation (10% rat liver S9 in standard cofactors). A dose range of 15 to 5000mcg/plate was employed. the vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within normal range.All positive control chemicals used induced marked increases in the frrequency of revertant colonies, both with and without metabolic activation. GSK1873183A caused a visible reduction in the growth of the bacterial lawns initially at 1500 and 5000mcg/plate. However, no increases in the frquency of revertant colonies was recorded for any of the bacterial strains, with any dose either with or without metabolic activation